InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-13.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Walker Marlan D, Conseiller Juridique. Insider active across 1 company, notably TherapeuticsMD, Inc.. Cumulatively, 10 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €1k. History available since 6 December 2022. The latest transaction was disclosed on 14 April 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
490 shares@ US$0.998532.2% of flowCommon StockSEC:0000905148-25-001215:0
Ideal exit: 9 Jan 2026 (T+270)
1,136 shares@ US$0.874767.8% of flowCommon StockSEC:0000905148-25-001190:0
Ideal exit: 4 Jan 2026 (T+270)
3,467 shares0Common StockSEC:0000905148-25-000737:0
70,000 shares0Common StockSEC:0001209191-23-057725:0
1,010 shares0Common StockSEC:0001209191-23-027361:0
3,030 shares0Common StockSEC:0001209191-23-024388:0
1,010 shares0Common StockSEC:0001209191-22-060587:0
230,000 sharesCommon StockSEC:0001209191-22-018682:0
50,500 sharesCommon StockSEC:0001387131-21-005570:0
50,500 sharesCommon StockSEC:0001387131-21-005570
10 of 10 declarations
About Walker Marlan D
Marlan D. Walker is the General Counsel of TherapeuticsMD, Inc. He is responsible for the company's legal affairs, including regulatory compliance and legal risk management. His expertise in business law is essential to support TherapeuticsMD's operations.
